홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Imidazole → (S)-3,5-di-(tert-butyldimethylsilyloxy)-pentan-2-one

HRID 1700957
인쇄

반응식

HRID 1700957 반응식
N1C=CN=C1.[Si:6](Cl)([C:9]([CH3:12])([CH3:11])[CH3:10])([CH3:8])[CH3:7].[Si:14]([O:21][C@H:22]1[CH2:26][CH2:25][O:24][C:23]1([OH:28])[CH3:27])([C:17]([CH3:20])([CH3:19])[CH3:18])([CH3:16])[CH3:15]>CN(C)C=O>[Si:14]([O:21][C@@H:22]([CH2:26][CH2:25][O:24][Si:6]([C:9]([CH3:12])([CH3:11])[CH3:10])([CH3:8])[CH3:7])[C:23](=[O:28])[CH3:27])([C:17]([CH3:20])([CH3:19])[CH3:18])([CH3:16])[CH3:15]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 795ImidazoleHCID 28928tert-Butyldimethylsilyl chlorideHCID 10704760(3S)-3-(tert-Butyldimethylsilyloxy)-2-hydroxy-2-methyl-tetrahydrofurane

생성물 1

HCID 11782967(S)-3,5-di-(tert-butyldimethylsilyloxy)-pentan-2-one수율 78.5%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

Imidazole (125 mg, 1.84 mmol, 2.2 equiv) and tert-butyl-dimethylsilyl chloride (139 mg, 0.92 mmol, 1.1 equiv) are added to a solution of (3S)-3-(tert-butyldimethylsilyloxy)-2-hydroxy-2-methyl-tetrahydrofurane 13 (194 mg, 0.83 mmol) in dimethyl formamide (800 μl). The mixture is stirred for 24 h at r.t. Purification of the reaction mixture by flash column chromatography (pentane/diethyl ether 20:1) affords (S)-3,5-di-(tert-butyidimethylsilyloxy)pentan-2-one 14 (226 mg, 78%) as a colourless oil. [α]D20=−11.8; [α]54620=−14.1 (c=1.0, CHCl3); 1H-NMR (200 MHz, CDCl3): δ(ppm)=4.16 (dd, 1H); 3.8-3.5 (m, 2H); 2.16 (s, 3H); 1.9-1.7 (m, 2H); 0.92 (s, 9H); 0.88 (s, 2H); 0.06 (s, 6H); 0.04 (s, 3H), 0.03 (s, 3H)

후처리

  1. customPurification of the reaction mixture by flash column chromatography (pentane/diethyl ether 20:1)

출처 및 근거

ORD 기록
ord-1a995e1ef2324338bb8184e52bad5b00
출처 데이터셋
uspto-grants-2002_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06350878B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트